Skip to content
Trial Eligibility
Menu

Gut Microbiota-Mediated Inflammatory Interactions Between AUD and HIV Infection

NCT06139224

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

Alcohol use disorder (AUD) has been associated with high prevalence of inflammation-associated co-morbidities in people living with HIV even those receiving effective antiretroviral therapy (ART). Our preliminary data support a model in which the combined insult of AUD and HIV on the gut, specifically on the microbiota and intestinal barrier integrity, exacerbates inflammation.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Alcohol Use Disorder
  • Human Immunodeficiency Virus

Eligibility basics and study details

Study type
Interventional
Phase
Not applicable
Ages
45 to 75 years
Sex
All
Healthy volunteers
Accepted
Sponsor
Rush University Medical Center
Last updated on ClinicalTrials.gov
June 4, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Illinois · 1

  • Ali Keshavarzian · Chicago, IL

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.